Bunnage Mark E.
EVP, Chief Scientific Officer
CIK: 2100735
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | S | 1,182 | $473.68 | $559,889.76 | View Details Filing |
| Feb 17, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | F | 1,110 | $483.75 | $536,962.50 | View Details Filing |
| Feb 17, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | S | 2,437 | $489.46 | $1,192,814.02 | View Details Filing |
| Feb 17, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | A | 2,584 | $0.00 | $0.00 | View Details Filing |
| Feb 13, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | F | 2,283 | $487.76 | $1,113,556.08 | View Details Filing |
| Feb 11, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | S | 2,021 | $460.43 | $930,529.03 | View Details Filing |
| Feb 10, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | F | 1,127 | $468.41 | $527,898.07 | View Details Filing |